FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225756869> ?p ?o ?g. }

• W4225756869 endingPage "e892" @default.
• W4225756869 startingPage "e880" @default.
• W4225756869 abstract "Black and Hispanic people with multiple sclerosis (MS) (pMS) have been found to have different disease courses or worse outcomes associated with MS compared to White pMS. They are also more likely to be negatively affected by social determinants of health, further worsening disparities in outcomes. As these disparities may affect treatment response, non-White pMS must be included in trials for greater generalizability of research and therefore more inclusive treatment plans. In this study, we aimed to evaluate how representation of non-White groups in phase III trials of approved disease-modifying therapies (DMTs) has evolved over time and how race and ethnicity are reported in medical journals and on manufacturer websites.We conducted a systematic review of the PubMed database from 1995 to June 2020 to identify manufacturer-sponsored phase III trials for Food and Drug Administration-approved MS DMTs. We explored how race and ethnicity were reported in trial publications. Using studies where information was available, we analyzed the representation of non-White pMS over time and compared to multinational census data. We reviewed patient- and health care provider (HCP)-facing websites of available DMTs to assess the dissemination of information on racial and ethnic representation in trials.A total of 44 phase III trial publications were reviewed, representing 45 trials, among which 17 (37.8%) did not report race or ethnicity, 14 (31.1%) reported race and ethnicity as proportion of White participants only, and 14 (31.1%) reported 2 or more races/ethnicities. When compared to multinational census data, non-White pMS were significantly underrepresented in MS trials. Due to lack of data, trends in representation of other races and ethnicities could not be assessed. No patient- or HCP-facing DMT websites reported data on race and ethnicity in pivotal trials. Study results are available on our study dashboard.Race and ethnicity are underreported in MS DMT trial publications and race and ethnic representation are omitted from manufacturer websites. When available, data show that non-White pMS are significantly underrepresented in MS trials. The availability of this information is crucial for patients, together with their HCPs, to make informed decisions about their care." @default.
• W4225756869 created "2022-05-05" @default.
• W4225756869 creator A5004768837 @default.
• W4225756869 creator A5006314689 @default.
• W4225756869 creator A5010761420 @default.
• W4225756869 creator A5026428428 @default.
• W4225756869 creator A5068178483 @default.
• W4225756869 creator A5077522095 @default.
• W4225756869 creator A5090347812 @default.
• W4225756869 creator A5090612440 @default.
• W4225756869 date "2022-01-19" @default.
• W4225756869 modified "2023-10-06" @default.
• W4225756869 title "Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs" @default.
• W4225756869 cites W1982661290 @default.
• W4225756869 cites W1991246584 @default.
• W4225756869 cites W2017946173 @default.
• W4225756869 cites W2022638262 @default.
• W4225756869 cites W2049320250 @default.
• W4225756869 cites W2062270162 @default.
• W4225756869 cites W2079478300 @default.
• W4225756869 cites W2081236926 @default.
• W4225756869 cites W2088754095 @default.
• W4225756869 cites W2133129329 @default.
• W4225756869 cites W2145172939 @default.
• W4225756869 cites W2172271216 @default.
• W4225756869 cites W2264209547 @default.
• W4225756869 cites W2560438049 @default.
• W4225756869 cites W2584171820 @default.
• W4225756869 cites W2893442500 @default.
• W4225756869 cites W2895801590 @default.
• W4225756869 cites W3045561006 @default.
• W4225756869 cites W3087487269 @default.
• W4225756869 cites W3093540699 @default.
• W4225756869 cites W3118615836 @default.
• W4225756869 cites W4238944663 @default.
• W4225756869 doi "https://doi.org/10.1212/wnl.0000000000013230" @default.
• W4225756869 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35046135" @default.
• W4225756869 hasPublicationYear "2022" @default.
• W4225756869 type Work @default.
• W4225756869 citedByCount "15" @default.
• W4225756869 countsByYear W42257568692022 @default.
• W4225756869 countsByYear W42257568692023 @default.
• W4225756869 crossrefType "journal-article" @default.
• W4225756869 hasAuthorship W4225756869A5004768837 @default.
• W4225756869 hasAuthorship W4225756869A5006314689 @default.
• W4225756869 hasAuthorship W4225756869A5010761420 @default.
• W4225756869 hasAuthorship W4225756869A5026428428 @default.
• W4225756869 hasAuthorship W4225756869A5068178483 @default.
• W4225756869 hasAuthorship W4225756869A5077522095 @default.
• W4225756869 hasAuthorship W4225756869A5090347812 @default.
• W4225756869 hasAuthorship W4225756869A5090612440 @default.
• W4225756869 hasConcept C126322002 @default.
• W4225756869 hasConcept C137403100 @default.
• W4225756869 hasConcept C138496976 @default.
• W4225756869 hasConcept C144024400 @default.
• W4225756869 hasConcept C149923435 @default.
• W4225756869 hasConcept C15744967 @default.
• W4225756869 hasConcept C19165224 @default.
• W4225756869 hasConcept C27158222 @default.
• W4225756869 hasConcept C512399662 @default.
• W4225756869 hasConcept C535046627 @default.
• W4225756869 hasConcept C59822182 @default.
• W4225756869 hasConcept C71924100 @default.
• W4225756869 hasConcept C74909509 @default.
• W4225756869 hasConcept C76509639 @default.
• W4225756869 hasConcept C86803240 @default.
• W4225756869 hasConceptScore W4225756869C126322002 @default.
• W4225756869 hasConceptScore W4225756869C137403100 @default.
• W4225756869 hasConceptScore W4225756869C138496976 @default.
• W4225756869 hasConceptScore W4225756869C144024400 @default.
• W4225756869 hasConceptScore W4225756869C149923435 @default.
• W4225756869 hasConceptScore W4225756869C15744967 @default.
• W4225756869 hasConceptScore W4225756869C19165224 @default.
• W4225756869 hasConceptScore W4225756869C27158222 @default.
• W4225756869 hasConceptScore W4225756869C512399662 @default.
• W4225756869 hasConceptScore W4225756869C535046627 @default.
• W4225756869 hasConceptScore W4225756869C59822182 @default.
• W4225756869 hasConceptScore W4225756869C71924100 @default.
• W4225756869 hasConceptScore W4225756869C74909509 @default.
• W4225756869 hasConceptScore W4225756869C76509639 @default.
• W4225756869 hasConceptScore W4225756869C86803240 @default.
• W4225756869 hasIssue "9" @default.
• W4225756869 hasLocation W42257568691 @default.
• W4225756869 hasLocation W42257568692 @default.
• W4225756869 hasOpenAccess W4225756869 @default.
• W4225756869 hasPrimaryLocation W42257568691 @default.
• W4225756869 hasRelatedWork W2062273356 @default.
• W4225756869 hasRelatedWork W2130057192 @default.
• W4225756869 hasRelatedWork W2134497802 @default.
• W4225756869 hasRelatedWork W2153763657 @default.
• W4225756869 hasRelatedWork W2156748995 @default.
• W4225756869 hasRelatedWork W2419209775 @default.
• W4225756869 hasRelatedWork W2498587162 @default.
• W4225756869 hasRelatedWork W2499945460 @default.
• W4225756869 hasRelatedWork W2576674945 @default.
• W4225756869 hasRelatedWork W2955439148 @default.
• W4225756869 hasVolume "98" @default.
• W4225756869 isParatext "false" @default.

• next